Omeprazole: Omeprazole Actavis is the new funded brand
Omeprazole is a medicine used to treat reflux and peptic ulcers.
The funded brand of omeprazole will change from Omezol Relief to Omeprazole Actavis.
Your new brand is available from 1 January 2018
- From 1 January 2018 Omeprazole Actavis will be fully funded.
- From 1 March 2018 a part payment may be required for Omezol Relief.
- From 1 June 2018 only Omeprazole Actavis will be fully funded. Omezol Relief will no longer be funded.
If you do want to keep using your current brand of omeprazole, you can ask your pharmacist to check the price and availability. PHARMAC cannot guarantee the availability or price of Omezol Relief after 1 June 2018.
Omeprazole Actavis works the same as the other brands
- Omeprazole Actavis will work in the same way as Omezol Relief. Omeprazole Actavis has the same active ingredient as other brands and is delivered to the body in the same way. This means it will have the same effect as the other brands
- Omeprazole Actavis has been thoroughly evaluated by Medsafe to ensure it’s safe and works the same as other brands
- It’s understandable that you might have questions about changing your medicine but you shouldn’t notice any difference when you change to Omeprazole Actavis. If you have any questions or concerns about changes to medicines, you should talk with your doctor, nurse or pharmacist.
Your new brand comes in a different coloured capsule
Your brand is changing to help us fund other medicines
A decision to change a medicine isn’t taken lightly. We’ve received expert advice about the appropriateness of making this change.
Our job is to make sure New Zealanders have access to the medicines they need. Making changes to medicines helps us achieve that by freeing up our limited budget to fund other medicines in the community.
Find out more
If you have any questions or concerns about changing brands, talk with your doctor, nurse or pharmacist.
You can also get more information from us at email@example.com or 0800 66 00 50.
Brand changes are common and healthcare professionals play a critical role in making the transition smooth for patients. Learn more with ‘Beyond the Brand’ at www.learnonline.health.nz(external link)
Last updated: 20 November 2017